There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| 1 | 38 | 792.3 |
| 2 | 22 | 792.25 |
| 1 | 27 | 792.2 |
| 5 | 118 | 792.15 |
| 2 | 59 | 792.1 |
| Ask | Qty | Orders |
|---|---|---|
| 792.9 | 4 | 107 |
| 792.95 | 3 | 76 |
| 793 | 1 | 5 |
| 793.05 | 4 | 13 |
| 793.1 | 1 | 27 |
Annual Revenue,rose 28.16%, in the last year to ₹3,930.8 Cr. Its sector's average revenue growth for the last fiscal year was 19.46%.Quarterly Revenue,rose 35.33% YoY to ₹1,195.9 Cr. Its sector's average revenue growth YoY for the quarter was 25.05%.Interest Coverage Ratio,is 4.09, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
Krishna Institute of Medical Sciences Limited (KIMS) is among India’s largest corporate healthcare providers, operating under the ‘KIMS Hospitals’ brand across South and West India. The Group’s integrated network offers a comprehensive range of multi‑disciplinary services, with a focus on affordable tertiary and quaternary care delivered through hospitals equipped with advanced clinical infrastructure . The Company, domiciled in India with its registered office in Secunderabad, Telangana, prepares standalone and consolidated financial statements and is listed on both BSE and NSE .
KIMS began with a single hospital and has grown steadily through strategic expansion and acquisitions, building a reputation for clinical depth supported by skilled professionals and strong patient‑centric systems . As of March 31, 2025, the Company had 13 subsidiaries (including those yet to commence operations) .
Key milestones include its stock market listing on June 28, 2021, and a sub‑division of equity shares from face value Rs 10 to Rs 2, approved on August 29, 2024, with a record date of September 13, 2024 .
– Dr. Bhaskara Rao Bollineni – Chairman & Managing Director
– Dr. Abhinay Bollineni – Director & Chief Executive Officer
– Sachin Ashok Salvi – Chief Financial Officer
– J R Nagajayanthi – Company Secretary & Compliance Officer
– Dandamudi Anitha – Whole‑time Director
– Share split: Equity shares were sub‑divided from face value Rs 10 each to Rs 2 each, as approved on August 29, 2024; the Company fixed September 13, 2024 as the record date .
– Acquisitions: The Company acquired Meda Institute of Podiatry Private Limited with effect from June 11, 2024, and Chalasani Hospitals Private Limited with effect from August 31, 2024 .
– Expansion pipeline: Beds are to be added shortly in cities including Mumbai, Bangalore and Bhubaneswar, as well as regions in Telangana and Andhra Pradesh; cities have been identified for expansion in FY 2025 .
– Network structure: KIMS continued to operate as a single reportable segment—medical and healthcare services—under its business model .
The intraday high for Krishna Inst Of Med Sci Ltd on the NSE today (04 Aug 2026) was ₹826.65. This compares to the 52-week high of ₹858.00 recorded on 06 Jul 2026. Today's high was -3.65% below the 52-week high.
For Q1 FY27, Krishna Inst Of Med Sci Ltd reported: Revenue (Net Sales): ₹4836.00 Cr - Up 6.01% year-on-year from ₹4562.00 Cr in Q4 FY26. Net Income (PAT): ₹665.00 Cr - Up 0.91% year-on-year from ₹659.00 Cr in Q4 FY26.
Krishna Inst Of Med Sci Ltd has delivered 9.83% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹858.00 on 06 Jul 2026 and a 52-week low of ₹575.80 on 27 Jan 2026. It is currently trading at ₹794.30 as of 04 Aug 2026.
The all-time high (ATH) for Krishna Inst Of Med Sci Ltd was ₹850.65, recorded on 03 Jul 2026. At the current price of ₹794.30, the stock is trading 6.62% below its all-time high. The all-time low recorded was ₹189.41 on 30 Jun 2021.
Krishna Inst Of Med Sci Ltd has delivered a return of 20.11% over the last 3 months. The stock was trading at ₹683.20 on 04 May 2026 and is currently at ₹794.30 as of 04 Aug 2026, reflecting a Gain of ₹111.10 per share over this period.
As of 04 Aug 2026, the share price of Krishna Inst Of Med Sci Ltd is ₹794.30 on the NSE and ₹794.75 on the BSE. The stock opened at ₹805.95, touched a high of ₹826.65 and a low of ₹790.15 during today's session.
Over the last 6 months, Krishna Inst Of Med Sci Ltd has given a return of 34.59%. The stock was priced at ₹609.70 on 04 Feb 2026 and has Rise to ₹794.30 as of 04 Aug 2026, a change of ₹184.60 per share.
No,Krishna Inst Of Med Sci Ltd has not declared any dividend over the past 5 years. The company paid a total dividend of N/A per share between FY2022 and FY2026, with the most recent dividend of ₹N/A per share. At the current market price of ₹794.30, the trailing dividend yield of Krishna Inst Of Med Sci Ltd stands at N/A%.
Krishna Inst Of Med Sci Ltd has delivered a 224.42% absolute return over the past 5 years, equivalent to a CAGR of 26.54% per annum. The stock was priced at ₹244.84 in Aug 2021 and has risen to ₹794.30 as of 04 Aug 2026. An investment of ₹1,00,000 in Krishna Inst Of Med Sci Ltd five years ago would be worth ₹3,24,420.00 today.
The intraday low for Krishna Inst Of Med Sci Ltd on the NSE today was ₹790.15. The stock's 52-week low stands at ₹575.80, recorded on 27 Jan 2026. Today's low is 37.23% above the 52-week low, indicating the stock is trading well above its yearly lows.
